| 1 | |
| 2 | Advanced oral lipid formulations of BCS class II and IV drugs for bioavailability enhancement |
| Language: | English |
| 3 | |
| 4 | |
| Language: | English |
| 5 | |
| 6 | |
| Language: | English |
| 7 | |
| 8 | |
| Language: | English |
| 9 | |
| 10 | Design and development of anti-IL-23/TNF-α bispecific domain antibody |
| Language: | English |
| 11 | |
| 12 | |
| Language: | English |
| 13 | |
| 14 | Development of human paraxonase 1 (PON1) as prophylactic against organophosphate poisoning |
| Language: | English |
| 15 | Hormonal therapy outcomes, Health-related quality of life and cost of Illness in West syndrome |
| 16 | |
| Language: | English |
| 17 | |
| 18 | |
| Language: | English |
| 19 | |
| 20 | Design, Synthesis and biological evaluation of N-heterocycles as potential anti-tubercular agents |
| Language: | English |